Free tool
FAERS Monitor: Detrol
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020771 or its brand name (Detrol, Tolterodine Tartrate). Reports on generic versions are filed under their own applications.
Reports
8,980
Serious
5,709
64% of reports
Hospitalization
2,688
Death reported
551
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective882
- fatigue586
- fall580
- nausea532
- dizziness466
- headache449
- asthenia437
- diarrhoea416
- pain401
- urinary tract infection377
- dyspnoea375
- constipation322
- vomiting311
- weight decreased307
- arthralgia306
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 383 |
| 2005 | 519 |
| 2006 | 455 |
| 2007 | 369 |
| 2008 | 408 |
| 2009 | 420 |
| 2010 | 600 |
| 2011 | 474 |
| 2012 | 537 |
| 2013 | 294 |
| 2014 | 498 |
| 2015 | 465 |
| 2016 | 488 |
| 2017 | 454 |
| 2018 | 446 |
| 2019 | 481 |
| 2020 | 373 |
| 2021 | 267 |
| 2022 | 276 |
| 2023 | 184 |
| 2024 | 249 |
| 2025 | 202 |
| 2026 | 136 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,179 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| urinary tract infectionSignal | 377 | 5.2 | 4.7 | 1,277 |
| fallSignal | 580 | 4.1 | 3.8 | 1,369 |
| constipationSignal | 322 | 3.5 | 3.1 | 566 |
| astheniaSignal | 437 | 2.7 | 2.5 | 483 |
| weight decreasedSignal | 307 | 2.6 | 2.3 | 298 |
| dizzinessSignal | 466 | 2.2 | 2.0 | 307 |
| fatigue | 586 | 1.8 | 1.6 | 200 |
| arthralgia | 306 | 1.7 | 1.5 | 94 |
| headache | 449 | 1.7 | 1.5 | 126 |
| nausea | 532 | 1.6 | 1.5 | 115 |
| drug ineffective | 882 | 1.6 | 1.5 | 193 |
| dyspnoea | 375 | 1.6 | 1.4 | 75 |
| vomiting | 311 | 1.5 | 1.4 | 61 |
| pain | 401 | 1.5 | 1.4 | 75 |
| diarrhoea | 416 | 1.5 | 1.4 | 73 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.